- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beximco Pharmaceuticals Ltd (BXPH)
Beximco Pharmaceuticals Ltd stock price live, this page displays DH BXPH stock exchange data. View the BXPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beximco Pharmaceuticals Ltd real time stock price chart below.
What Is the Beximco Pharmaceuticals Ltd Stock Price Today?
The Beximco Pharmaceuticals Ltd stock price today is 147.20.
What Is the Stock Symbol for Beximco Pharmaceuticals Ltd?
The stock symbol for Beximco Pharmaceuticals Ltd is "BXPH."
What Stock Exchange Does Beximco Pharmaceuticals Ltd Trade On?
Beximco Pharmaceuticals Ltd is listed and trades on the DSE stock exchange.
Is Beximco Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Beximco Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BXPH quote. (ISIN: BD0453BXPH04)
What Is the Beximco Pharmaceuticals Ltd Stock Price Today?
The Beximco Pharmaceuticals Ltd stock price today is 147.20.
What Is the Stock Symbol for Beximco Pharmaceuticals Ltd?
The stock symbol for Beximco Pharmaceuticals Ltd is "BXPH."
What Stock Exchange Does Beximco Pharmaceuticals Ltd Trade On?
Beximco Pharmaceuticals Ltd is listed and trades on the DSE stock exchange.
Is Beximco Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Beximco Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BXPH quote. (ISIN: BD0453BXPH04)
147.20
-0.40(-0.27%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
147.00
148.70
52 wk Range
99.50
158.50
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
147.00148.70
52 wk Range
99.50158.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BXPH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
198.55
Upside
+34.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Beximco Pharmaceuticals proposes 47.5% cash dividend- Investing.com
Beximco Pharmaceuticals reports 20% profit increase- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 198.55
(+34.88% Upside)
Earnings
Latest Release
Jun 24, 2026
EPS / Forecast
4.98 / --
Revenue / Forecast
13.63B / --
Compare BXPH to Peers and Sector
Metrics to compare | BXPH | Peers Peers - average of corresponding metrics from companies closely matching BXPH: SQURPHARMA, RENATA, 524804, 600750, 500087 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBXPHPeersSector |
|---|---|---|---|---|
P/E Ratio | 7.6x | 16.7x | −0.4x | |
PEG Ratio | - | 0.22 | 0.00 | |
Price/Book | 1.1x | 2.3x | 2.6x | |
Price / LTM Sales | 1.2x | 3.1x | 3.0x | |
Upside (Analyst Target) | 34.5% | 26.7% | 56.4% | |
Fair Value Upside | Unlock | 11.9% | 7.9% | Unlock |
Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. Beximco Pharmaceuticals PLC. was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Beximco Pharmaceuticals (BXPH) Stock Price Today?
The Beximco Pharmaceuticals stock price today is 147.20 BDT.
What Stock Exchange Does Beximco Pharmaceuticals Trade On?
Beximco Pharmaceuticals is listed and trades on the Dhaka Stock Exchange.
What Is the Stock Symbol for Beximco Pharmaceuticals?
The stock symbol for Beximco Pharmaceuticals is "BXPH."
Does Beximco Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?
The Beximco Pharmaceuticals dividend yield is 5.45%.
What Is the Beximco Pharmaceuticals Market Cap?
As of today, Beximco Pharmaceuticals market cap is 65.67B BDT.
What Is Beximco Pharmaceuticals's Earnings Per Share (TTM)?
The Beximco Pharmaceuticals EPS (TTM) is 19.39.
From a Technical Analysis Perspective, Is BXPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Beximco Pharmaceuticals Stock Split?
Beximco Pharmaceuticals has split 13 times.
How Many Employees Does Beximco Pharmaceuticals Have?
Beximco Pharmaceuticals has 1223 employees.
What is the current trading status of Beximco Pharmaceuticals (BXPH)?
As of Oct 02, 2026, Beximco Pharmaceuticals (BXPH) is trading at a price of 147.20 BDT, with a previous close of 87.20 BDT. The stock has fluctuated within a day range of 147.00 BDT to 148.70 BDT, while its 52-week range spans from 99.50 BDT to 158.50 BDT.
What Is Beximco Pharmaceuticals (BXPH) Price Target According to Analysts?
The average 12-month price target for Beximco Pharmaceuticals is 198.55 BDT, with a high estimate of 258.6 BDT and a low estimate of 138.5 BDT. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +34.88% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.